Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $692.4100 (-1.8%) ($686.8500 - $692.4100) on Thu. Sep. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 37 | Latest Price | $692.4100(-1.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -0.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) DIA(39%) SPLV(37%) IWD(35%) SDY(34%) | Factors Impacting REGN price | REGN will decline at least -1.445% in a week (0% probabilities). TBT(-13%) UUP(-6%) VIXM(-5%) EDOC(-4%) VXX(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $695.36(-0.42%) | 10 Day Moving Average | $698.12(-0.82%) | 20 Day Moving Average | $680.83(1.7%) | To recent high | -4.5% | To recent low | 20.7% | Market Cap | $73.415b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |